title: UK drug agency announces review of use of alteplase after stroke.
authors.affiliation: The BMJ.
authors.forename: Deborah
authors.initials: D
authors.lastname: Cohen
authors.affiliation: The BMJ.
authors.forename: Helen
authors.initials: H
authors.lastname: Macdonald
mesh_terms: D002545:Brain Ischemia / Q000188:drug therapy*; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D011358:Product Surveillance, Postmarketing; D020521:Stroke / Q000188:drug therapy*; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*; D006113:United Kingdom
chemical_list: D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator